Resectable Intrahepatic Cholangiocarcinoma
Oncology
Prevalence
2.5 / 100K
Incidence
1.3 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Resectable Intrahepatic Cholangiocarcinoma?
There are 1 clinical trial targeting Resectable Intrahepatic Cholangiocarcinoma tracked by BioSniper.
What is the prevalence of Resectable Intrahepatic Cholangiocarcinoma?
The estimated prevalence of Resectable Intrahepatic Cholangiocarcinoma is approximately 2.5 per 100,000 population.
Deep-dive into Resectable Intrahepatic Cholangiocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis